Shares of Fractyl Health, Inc. are all set to begin trading on the Nasdaq Global Market, under the ticker symbol, "GUTS" today (Feb 2, 2024).
The Lexington, Massachusetts-based Fractyl Health is a metabolic therapeutics company developing treatments for metabolic diseases, including Type 2 Diabetes, or T2D, and obesity.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com